The Cooper Companies, Inc.(COO)

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, myopia, ocular dryness and eye fatigues in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides medical devices, fertility, genomics, diagnostics, and contraception to health care professionals and patients worldwide. It offers surgical and office products, including PARAGARD, uterine manipulators, retractors, closure products, point of care products, LEEP products, endosee, and illuminate and fetal pillows; fertility products and services, such as fertility consumables and equipment, and embryo options and preimplantation genetic testing. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Latest News & Analysis
Cooper Companies (COO) Q1 2025 Earnings: Revenue Miss Signals Challenges Ahead?
Cooper Companies' Q1 2025 earnings revealed a revenue miss despite matching EPS estimates. CooperVision's growth contrasts with CooperSurgical's challenges.
CooperCompanies (COO) Q1 2025 Earnings Preview: Market Trends and Analysis
CooperCompanies (COO) prepares for Q1 2025 earnings amid market shifts. This analysis covers segments, acquisitions, trends, and expectations, offering key insights for investors.
CooperCompanies (COO) Q1 2025 Earnings Preview: Navigating Growth in Vision Care & Women's Health
CooperCompanies (COO) Q1 2025 earnings preview: Navigating mixed market signals, strategic acquisitions, and international expansion. Key insights for investors.
CooperCompanies (COO) Q1 2025 Earnings Preview: Acquisition Impact
A comprehensive analysis of CooperCompanies' Q1 2025 earnings preview, acquisition impacts, and strategic market positioning. Key insights for investors and analysts.
CooperCompanies (COO): Q1 2025 Earnings Preview and Analysis
Comprehensive analysis of The Cooper Companies (COO) ahead of Q1 2025 earnings, examining market trends, financial health, and strategic initiatives.
CooperCompanies: Strategic Outlook and Market Analysis
CooperCompanies (COO) gears up for Q1 2025 earnings amid strategic growth and market shifts. Revenue focus sharpens as acquisitions and global trends steer outlook.
CooperCompanies (COO): Q1 2025 Earnings Preview and Market Outlook
CooperCompanies (COO) navigates the medical device landscape amidst Q1 2025 earnings preview and strategic market positioning. Stay informed with data-driven insights.
CooperCompanies (COO): Q1 2025 Outlook and Market Analysis
CooperCompanies faces mixed market signals amid acquisition rumors and competitive pressures. Q1 2025 outlook and strategic shifts analyzed.
CooperCompanies: Analyzing Financial Performance and Future Growth in 2025
CooperCompanies' recent performance analyzed: earnings, international revenue, acquisitions, and industry trends shaping its 2025 outlook.
CooperCompanies (COO): Financial Growth & Strategy in 2025
A comprehensive intraday analysis of CooperCompanies' financial performance, strategic acquisitions, and market trends driving growth in 2025.